These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2488504)
1. [Hematologic effects of dapsone (Disulone)]. Bordessoule D; Liozon E; Cransac M; Bonnetblanc JM; Vidal E; Weinbreck P; Liozon F Rev Med Interne; 1989; 10(6):531-6. PubMed ID: 2488504 [No Abstract] [Full Text] [Related]
2. Adverse effects of dapsone. Graham WR Int J Dermatol; 1975 Sep; 14(7):494-500. PubMed ID: 1099035 [No Abstract] [Full Text] [Related]
3. Hematologic side-effects of dapsone. Wilson JR; Harris JW Ohio State Med J; 1977 Aug; 73(8):557-60. PubMed ID: 887243 [No Abstract] [Full Text] [Related]
4. Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity. Figueiredo MS; Pinto BO; Zago MA Acta Haematol; 1989; 82(3):144-5. PubMed ID: 2510435 [TBL] [Abstract][Full Text] [Related]
5. [Methemoglobinemia and hemolytic anemia induced by Disulon]. De Prost Y; Hornac P; Galacteros F; Penev M; Revuz J; Touraine R Ann Dermatol Venereol; 1982; 109(12):1025-9. PubMed ID: 7171199 [TBL] [Abstract][Full Text] [Related]
6. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy. Deps P; Guerra P; Nasser S; Simon M Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031 [TBL] [Abstract][Full Text] [Related]
8. Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency. Ganer A; Knobel B; Fryd CH; Rachmilewitz EA Isr J Med Sci; 1981 Aug; 17(8):703-4. PubMed ID: 6765904 [TBL] [Abstract][Full Text] [Related]
9. [Side effects of treatment with sulfones]. Revuz J; Hornac P LARC Med; 1981 Dec; 1(3):68-70. PubMed ID: 6298511 [No Abstract] [Full Text] [Related]
10. Sulfones and sulfonamides in dermatology today. Lang PG J Am Acad Dermatol; 1979 Dec; 1(6):479-92. PubMed ID: 528697 [TBL] [Abstract][Full Text] [Related]
11. Dapsone Induced Agranulocytosis and Hemolytic Anemia in Immune Thrombocytopenic Purpura. Bartakke SP; Sampagar AA; Reddy NA; Kangle R Indian J Pediatr; 2020 Oct; 87(10):856. PubMed ID: 32140985 [No Abstract] [Full Text] [Related]
12. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity. Ranawaka RR; Mendis S; Weerakoon HS Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991 [TBL] [Abstract][Full Text] [Related]
13. Chronic dapsone use causing methemoglobinemia with oxidative hemolysis and dyserythropoiesis. Gallardo CA; Fan BE; Lim KGE; Kuperan P Am J Hematol; 2021 Dec; 96(12):1715-1716. PubMed ID: 33524190 [No Abstract] [Full Text] [Related]
14. Acute visual loss following dapsone-induced methemoglobinemia and hemolysis. Hanuschk D; Kozyreff A; Tafzi N; Tennstedt D; Hantson P; Saint-Marcoux F Clin Toxicol (Phila); 2015 Jun; 53(5):489-92. PubMed ID: 25858136 [TBL] [Abstract][Full Text] [Related]
15. Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage. Manfredi G; De Panfilis G; Zampetti M; Allegra F Br J Dermatol; 1979 Apr; 100(4):427-32. PubMed ID: 454569 [TBL] [Abstract][Full Text] [Related]
16. Serum hemopexin in patients with dermatitis herpetiformis on dapsone (di(4-aminophenyl)sulphone). Kastrup W; Lindstedt G; Lundberg PA; Mobacken H Arch Dermatol Res (1975); 1975 Dec; 254(3):225-32. PubMed ID: 1211972 [TBL] [Abstract][Full Text] [Related]
17. The adverse effects of drugs on the blood. McVie JG Br J Clin Pract; 1973 Aug; 27(8):300-8. PubMed ID: 4586638 [No Abstract] [Full Text] [Related]